纳米药物的风险及控制

The Risks and the Controls for Nanopharmaceuticals

纳米技术在药学领域的应用表现为药物的靶向传递和纳米级粒子药物。纳米药物的风险表现为对人健康的风险和对环境损害的风险。应对纳米药物带来的风险和伦理问题,需要创建风险评估标准;维护人的知情权和自主权;遵守自然规律,严格规范生产设计;强化政策导向、监督管理和法律保障。

The applications of Nanotechnology in the field of pharmacy mainly present in two ways. One is targeted drug delivery; another is substantial Nanopharmaceutieals on the scale of Nano. The risks of Nanopharmaceuticals present the risks for human health and the risks of the harms for environment. In order to deal with the risks of Nanopharmaceuticals and ethical problems, it is necessary to enhance countermeasures. It include： to establish the standards of assessment for the risks; to protect the human rights of informed consent and autonomy; to stipulate manufacturing designs for Nanopharmaceuticals according to the rule of nature; to enhance the direction of the policy, regulatory management and the protection of law.